| Literature DB >> 25846621 |
Jacob Thomas1, Sanam Mustafa, Jacinta Johnson, Lauren Nicotra, Mark Hutchinson.
Abstract
Opioids are considered the gold standard for the treatment of moderate to severe pain. However, heterogeneity in analgesic efficacy, poor potency and side effects are associated with opioid use, resulting in dose limitations and suboptimal pain management. Traditionally thought to exhibit their analgesic actions via the activation of the neuronal G-protein-coupled opioid receptors, it is now widely accepted that neuronal activity of opioids cannot fully explain the initiation and maintenance of opioid tolerance, hyperalgesia and allodynia. In this review we will highlight the evidence supporting the role of non-neuronal mechanisms in opioid signalling, paying particular attention to the relationship of opioids and immune signalling.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25846621 DOI: 10.1007/978-3-662-46450-2_11
Source DB: PubMed Journal: Handb Exp Pharmacol ISSN: 0171-2004